Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum.
about
Topical tacrolimus for atopic dermatitisPimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infantsEfficacy of topical calcineurin inhibitors in vitiligo.Is pimecrolimus cream (1%) an appropriate therapeutic agent for the treatment of external ear atopic dermatitis?Topical pimecrolimus for skin disease other than atopic dermatitis.Assigning new roles to topical tacrolimus.The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.The use of topical calcineurin inhibitors in lupus erythematosus: an overview.Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema.Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs.Hand dermatitis: a review of clinical features, prevention and treatment.Association of atopy and tentative diagnosis of skin cancer - results from occupational skin cancer screenings.Topical calcineurin inhibitors in systemic lupus erythematosus.Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a > 2000 patient study.Diagnosis and management of common dermatoses in children: atopic, seborrheic, and contact dermatitis.Conflicts of interest and authorship of industry-sponsored publications.Guidelines for treatment of atopic eczema (atopic dermatitis) part I.
P2860
Q24186624-70AF6055-9C02-4A2A-BB14-3F976BDB46B9Q28086973-FE230A61-BAA8-4A79-AA0A-2AEF6319824AQ34553952-622C5D8D-E579-4B07-AF93-F03714C6A0FEQ36577730-39A318A3-A044-4C17-9BE2-E684D0A9FB26Q36613896-D493D113-36A4-4375-B96F-4F74675B785CQ36904866-64881CAE-41D3-4307-998B-B6CCE0DBDA70Q36940038-763F637B-7D81-4BB5-8EAA-5B1436D467B9Q37001577-42584FBB-D3E0-4CA7-89FE-6B8BA442CAC4Q38123240-D63AC7EB-766B-40E4-9D6F-2359A1368ED1Q38266892-148CD60E-EFFB-4C2E-86B0-EBD947AF4C42Q38446594-57CAFA52-7B63-4C74-B63A-4B53D6523C24Q38691725-623D2F97-3C1D-4434-865F-BC82E86D890AQ40122276-7921912E-FF78-4E59-814C-5499AB1B41E5Q46797204-91E7503A-0004-4FFF-A957-363C611A95C7Q46868092-0179034C-27D7-4C40-BF58-FA7AC5B0AF9EQ47589099-007E3C59-B972-4A94-9510-342187A1C3CBQ50927518-4006ED6A-0091-4C99-B6CF-EE6F683EFBB9
P2860
Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Review of the potential photo- ...... he European Dermatology Forum.
@ast
Review of the potential photo- ...... he European Dermatology Forum.
@en
type
label
Review of the potential photo- ...... he European Dermatology Forum.
@ast
Review of the potential photo- ...... he European Dermatology Forum.
@en
prefLabel
Review of the potential photo- ...... he European Dermatology Forum.
@ast
Review of the potential photo- ...... he European Dermatology Forum.
@en
P2093
P2860
P1476
Review of the potential photo- ...... he European Dermatology Forum.
@en
P2093
Behrendt H
Braathen L
Dubertret L
Giannetti A
Hönigsmann H
P2860
P304
P356
10.1111/J.1468-3083.2005.01315.X
P577
2005-11-01T00:00:00Z